Therapeutic Targets of the TNF Superfamily
Tumor necrosis factor (TNF) superfamily is a rapidly growing family of cytokines that interacts with a corresponding superfamily of receptors. Ligand-receptor interactions of this superfamily are involved in numerous biological processes ranging from hematopoiesis to pleiotropic cellular responses,...
Clasificación: | Libro Electrónico |
---|---|
Autor Corporativo: | |
Otros Autores: | |
Formato: | Electrónico eBook |
Idioma: | Inglés |
Publicado: |
New York, NY :
Springer New York : Imprint: Springer,
2009.
|
Edición: | 1st ed. 2009. |
Colección: | Advances in Experimental Medicine and Biology,
647 |
Temas: | |
Acceso en línea: | Texto Completo |
Tabla de Contenidos:
- Overview of TNF Superfamily: A Chest Full of Potential Therapeutic Targets
- Therapeutic Interventions Targeting CD40L (CD154) and CD40: The Opportunities and Challenges
- Targeting TNF for Treatment of Cancer and Autoimmunity
- Targeting of BAFF and APRIL for Autoimmunity and Oncology
- The Role of FasL and Fas in Health and Disease
- OX40 (CD134) and OX40L
- Targeting CD70 for Human Therapeutic Use
- 4-1BB as a Therapeutic Target for Human Disease
- RANK(L) as a Key Target for Controlling Bone Loss
- Targeting the LIGHT-HVEM Pathway
- GITR: A Modulator of Immune Response and Inflammation
- Targeting CD30/CD30L in Oncology and Autoimmune and Inflammatory Diseases
- Tumor Necrosis Factor Receptor Superfamily Member 21: TNFR-Related Death Receptor-6, DR6
- TRAIL and Other TRAIL Receptor Agonists as Novel Cancer Therapeutics
- Therapeutic Potential of VEGI/TL1A in Autoimmunity and Cancer.